Author Interviews

Healthcare has a data problem — not a shortage of it, but an inability to act on it. The average large health system generates hundreds of millions of clinical events annually. Claims databases hold years of longitudinal patient history. EHRs log every medication, every vital sign, every lab result. And most of that data sits in silos, incompatible formats, and legacy systems that were never designed to talk to each other. Organizations that turn clinical, pharmaceutical and financial data into better decisions use purpose-built healthcare analytics platforms. In 2026, these platforms must support FHIR interoperability, near real-time population health analytics, value-based care, and AI-driven insights. But not all healthcare analytics solutions are the same. The market ranges from FHIR-native clinical intelligence platforms to general-purpose BI tools with healthcare connectors. Choosing the wrong solution can lead to costly implementations, limited clinical capabilities, and analytics that can't scale with your healthcare data. This guide profiles seven leading healthcare analytics solutions for 2026, evaluated on clinical depth, interoperability support, analytical sophistication, and fit for healthcare-specific workflows. They are not all the same — and that distinction matters.

The Error Stakes in Healthcare Translation

A mistranslated dosage, a misread allergy notation, a discharge instruction that says the opposite of what the physician intended. Research published in StatPearls via the National Library of Medicine estimates that approximately 400,000 hospitalized patients experience preventable harm each year, and communication failures rank as the leading root cause of sentinel events across healthcare systems. In 2024, industry data indicated that language barriers and communication breakdowns contribute to nearly 50% of adverse events in hospital settings. Global healthcare organizations face a specific and underappreciated dimension of this risk: multilingual communication. As patient populations grow more linguistically diverse and clinical research expands across borders, the quality of translated content, from patient consent forms to pharmaceutical labeling to discharge instructions, directly affects safety outcomes. [caption id="attachment_74539" align="aligncenter" width="500"]ai-healthcare-translation Photo by RDNE Stock project[/caption] The challenge has deepened with the rapid adoption of AI-based translation. As healthcare organizations have integrated large language models into their document workflows, a critical flaw has emerged. Individual leading AI models hallucinate or produce translation errors at rates ranging from 10% to 18% of translation tasks, according to data synthesized from the Intento State of Translation Automation 2025 and WMT24 benchmarks. For a sector where error tolerance is effectively zero, that rate is a structural liability. This review profiles 10 translation and localization platforms evaluated for healthcare applicability, covering clinical document fidelity, regulatory compliance, human review availability, and error mitigation architecture. For additional context on how AI adoption is reshaping clinical workflows, this publication's recent review of healthcare AI companies provides a useful reference frame.

MedicalResearch.com Interview with: [caption id="attachment_74522" align="alignleft" width="222"]Dr Daniel Liang-Dar HwangBSc, MBiotech, MSc, PhD ARC DECRA Fellow Institute for Molecular Bioscience The University of Queensland Brisbane, Australia and Monell Chemical Senses Center Philadelphia, PA, USA Dr. Daniel Hwang[/caption] Dr. Daniel Liang-Dar Hwang BSc, MBiotech, MSc, PhD ARC DECRA Fellow Institute for Molecular Bioscience The University of Queensland Brisbane, Australia and Monell Chemical Senses Center Philadelphia, PA, USA   MedicalResearch.com: What is the background for this study? What are the main findings? Response: One of the biggest challenges in nutrition research is distinguishing causation from correlation. People who consume particular foods often differ in many other ways, such as income, education, physical activity, or overall health, making it difficult to determine whether a food itself influences disease risk. Mendelian randomization has emerged as a powerful tool for investigating causal relationships by using genetic variants as proxies for exposures. However, finding genetic variants that reliably reflect what people eat remains a major challenge. In this study, we developed a biologically informed framework for instrument selection using genetic variation in taste and smell receptor genes. Because taste and smell are major biological drivers of food choice, variants in these genes may provide biologically meaningful proxies for studying dietary exposures. We examined more than 1,200 genetic variants in taste and smell receptor genes and tested their associations with preferences for 140 foods and beverages in more than 160,000 participants. We identified 700 significant gene–food associations, many of which were also linked to actual food intake and replicated in an independent cohort. We then used these biologically informed variants in Mendelian randomization analyses to investigate potential causal relationships between diet and health, demonstrating how sensory genetics can be used to strengthen causal inference in nutrition research and identify foods that may influence disease risk.

Semaglutide Linked to Fewer Bone Fractures Despite Greater Weight Loss in Type 2 Diabetes

[caption id="attachment_74422" align="alignleft" width="200"]Jairo Norena Velasquez, Dr. Norena Velasquez[/caption] MedicalResearch.com Interview with: Jairo Norena Velasquez, MD Associate Division Chief, Endocrinology Division Alameda Health System Oakland, California
MedicalResearch.com: What is the background for this study? What are the main findings?

Response: Type 2 diabetes is associated with a paradoxically elevated fracture risk — up to three times higher than the general population — despite normal or even elevated bone mineral density. The underlying problem is poor bone quality driven by chronic hyperglycemia, advanced glycation end-product accumulation, and increased cortical porosity. Compounding this, intentional weight loss — a cornerstone of diabetes treatment — can accelerate bone loss by reducing mechanical loading on the skeleton.

Semaglutide is one of the most effective weight-loss agents available, yet direct real-world comparisons of its skeletal effects against other active weight-loss therapies were lacking.

Using the Atropos Health Eos EHR database — 161 million US patients from 2016 to 2023 — we compared fracture incidence and BMI change in adults with type 2 diabetes initiating semaglutide versus dulaglutide, phentermine/topiramate, or bupropion/naltrexone, using high-dimensional propensity score matching (17,506 pairs per group).

Semaglutide was associated with greater weight loss (mean delta BMI −1.9 vs. −1.2 kg/m²; difference −0.72 kg/m², p < 0.001) and a 15% reduction in fracture incidence (HR 0.85, 95% CI 0.77–0.93; p < 0.001) over a mean follow-up of 3.6 years.

[caption id="attachment_74358" align="aligncenter" width="500"]healthy-dental-gums-pexels.jpg Photo by Kasim H[/caption]

The Link Between Gum Disease and Heart Health: What You Need to Know

Many people may not realise that your gums and your heart are physically connected. Evidence points over and over again to the fact that people with gum disease have a higher risk of heart problems. The biggest reason seems to be that when you have an infection in your mouth, it causes the blood vessels in your whole body to get inflamed. So it is not just teeth and gum problems that come from bad gum health. The conditions that can affect your whole body might be signaled to you at this point.

The reason why it helps to know about this connection between gum disease and heart problems is that bacteria can travel quite easily when there is inflammation. It is very likely that when gums become infected, the same bacteria responsible for the swelling and bleeding can get into the blood through the soft tissues. In fact, it is the continuous inflammatory response of the body that is suspected as the cause of the arteries getting hard and narrowed. Per research, gum disease does not directly cause heart attacks, but the correlation is strong enough that dentists and doctors treating heart diseases are now including oral hygiene as a part that needs to be taken into consideration.

MedicalResearch.com Interview with: [caption id="attachment_74329" align="alignleft" width="150"]Chun Sing (Jason) Lam, PhDPostdoctoral Research Fellow Integrative Medicine and Wellness Service Department of Medicine Memorial Sloan Kettering Cancer Center Chun Sing Lam, PhD[/caption] Chun Sing (Jason) Lam, PhD Postdoctoral Research Fellow Integrative Medicine and Wellness Service Department of Medicine Memorial Sloan Kettering Cancer Center MedicalResearch.com: What is the background for this study? What are the main supplements utilized by Americans? Response: Dietary supplement use is very common among U.S. adults, but patterns of use have changed substantially over time. The supplement market has expanded, with many products now marketed for different uses. But long-term national data are limited. In this study, we analyzed 25 years of nationally representative data from the National Health and Nutrition Examination Survey, from 1999 through August 2023, including 63,442 U.S. adults. Overall supplement use increased from about 51% of U.S. adults in 1999–2000 to about 60% in 2021–2023. Use of four or more supplements also increased, from 8.8% to 15%. One notable finding was that multivitamin/multimineral use declined modestly while use of individual vitamins, minerals, and specialty supplements increased. One important finding was the increase among older adults. Supplement use among adults aged 65 years and older increased from about 62% to 78%, which was the largest increase among demographic subgroups. Notable increases were seen for vitamin D, zinc, vitamin K, biotin, vitamin B12, and omega-3. Emerging trends were also seen for non-vitamin non-mineral supplements such as turmeric/curcumin, probiotics/prebiotics, collagen, elderberry, ashwagandha, and hyaluronic acid. These trends likely reflect growing consumer interest in immune support, gut health, and skin and joint health.

Editor's Note: Cannabis laws and regulations vary by country, state, and territory. This interview is for educational purposes only. Cannabis products discussed here are not endorsed by MedicalResearch.com. Patients should consult their oncologist or healthcare provider before using any cannabis or cannabinoid product, particularly during cancer treatment. Cannabis products should not be used while driving, by children, if pregnant, nursing or planning to become pregnant or mixed with other substances that can affect cognition. Cannabis products may also be contraindicated in other medical conditions or situations.

MedicalResearch.com: What is the background for this documentary? What are the primary components of cannabis plants? Response: I created Cannabis and Cancer because cannabis is now widely discussed by patients, clinicians, policymakers, and the general public, but there is still a lot of confusion about what the science actually says. Much of the public conversation treats cannabis as either broadly harmful or broadly beneficial. The reality is more complex. The documentary is meant to separate questions that are often conflated: whether cannabis exposure may influence the risk of developing cancer, whether cannabis use may affect cancer treatment or symptoms, and whether it may influence survival after a cancer diagnosis. These are very different scientific questions, and each one requires a different type of evidence. Cannabis plants contain many biologically active compounds. The most widely discussed are cannabinoids, especially THC and CBD. THC is the main intoxicating compound and is responsible for many of the psychoactive effects. CBD is not intoxicating in the same way, but it still has biological effects. Cannabis also contains other cannabinoids, terpenes, flavonoids, and plant compounds that may influence how different products affect the body.

MedicalResearch.com Interview with: [caption id="attachment_74111" align="alignleft" width="92"]Luis A. Rodriguez, PhD, MPH, RDResearch Scientist, Kaiser Permanente Northern California Division of Research Assistant Professor, Department of Health System Sciences Kaiser Permanente Bernard J. Tyson School of Medicine Assistant Adjunct Professor, Department of Epidemiology & Biostatistics University of California, San Francisco Dr. Rodriguez[/caption] Luis A. Rodriguez, PhD, MPH, RD Research Scientist, Kaiser Permanente Northern California Division of Research Assistant Professor, Department of Health System Sciences Kaiser Permanente Bernard J. Tyson School of Medicine Assistant Adjunct Professor, Department of Epidemiology & Biostatistics University of California, San Francisco ADA 2026 Poster Presentation: Machine-Learning Modeling for T2DM Prediction in over 3 Million Adults American Diabetes Association 85th Scientific Sessions, June 2026
MedicalResearch.com: What is the background for this study? What are the risk factors used to develop the prediction model? Response: Type 2 diabetes develops gradually over many years, often without clear warning signs. As a result, it can be difficult for health systems to identify which adults are most likely to benefit from prevention efforts before the disease develops. In this study, we used electronic health record data from more than 3 million adults in Kaiser Permanente Northern California to develop a prediction model that estimates an individual's risk of developing type 2 diabetes over 1, 3, and 10 years. The model is based on information routinely collected during clinical care, including age, sex, race/ethnicity, body mass index, blood glucose levels, smoking, physical activity, medical and family history, and medication use. By combining these clinical, biological and behavioral factors, the model provides a more comprehensive assessment of diabetes risk than traditional screening approaches.

How HPLC and LC-MS Testing Support UK Peptides

Please note: The peptides discussed in this article are sold strictly for laboratory and in vitro research purposes only. They are not approved for human use, consumption, or medical treatment. These compounds have not been evaluated by the FDA or equivalent regulatory bodies for safety or efficacy in humans. Selling peptides for human use violates UK law and equivalent regulations in many jurisdictions. MedicalResearch.com does not endorse the use of research peptides outside of properly supervised laboratory settings. Always consult a qualified healthcare provider before making any decisions regarding medical treatment.

Analytical testing has become an essential component in the sourcing and use of synthetic peptides for laboratory research. Accurate peptide identity confirmation is critical to ensure that the material employed in experimental assays corresponds precisely to the intended compound. This verification supports reproducibility and reliability in scientific studies involving peptides. This article explores the complementary roles of high-performance liquid chromatography (HPLC) and liquid chromatography–mass spectrometry (LC-MS) in peptide analysis. It focuses on their application in verifying peptide purity and molecular identity, emphasizing the importance of lot-specific certificates of analysis (COAs) and cold-chain handling in maintaining material integrity. While UKPeptides.com is referenced as an example of a supplier providing analytical documentation, the principles discussed are broadly applicable across research peptide sourcing.

Editor's note: This piece discusses mental health issues. If you have experienced suicidal thoughts or have lost someone to suicide and want to seek help, you can contact the Crisis Text Line by texting "START" to 741-741 or call the Suicide Prevention Lifeline at 800-273-8255. merging-integrative-medicine-and-mental-health Recent epidemiological data underscore severe public health disparities among underserved demographics. African Americans and Hispanics consistently demonstrate lower rates of mental health service utilization compared to Whites, despite experiencing similar or higher prevalence of trauma, stress, and crisis. Furthermore, LGBTQ+ populations, especially gay men and trans people, consistently demonstrate high rates of mental health need and suicide attempts. Further marginalization based on income, gender, disability, and education levels also exacerbate these gaps. In response to these alarming statistics, The Holistic Healing Source for Marginalized Society recently convened The 2026 Free Community Mental Health Breakfast. By merging integrative medicine with community-level mental health advocacy, the symposium aimed to promote comprehensive wellness and immediately accessible resources for vulnerable groups.

  neck-problems-not-to-be-ignored.png

Common Neck Problems People Should Never Ignore

Neck discomfort has become increasingly common in modern life. Many people spend long hours sitting at desks, looking down at phones, or working on computers without realizing how much strain these habits place on the neck and upper spine. While occasional stiffness after a long day may seem harmless, persistent neck pain or unusual symptoms can sometimes signal more serious problems that should not be ignored. The neck supports the weight of the head while also protecting important nerves and spinal structures that affect movement, sensation, and overall body function. When these structures become irritated or compressed, symptoms may spread beyond the neck itself and begin affecting the shoulders, arms, hands, or even daily activities like sleeping and driving. Understanding common neck problems and recognizing warning signs early can help people seek appropriate care before symptoms begin interfering with their quality of life.

Editor's note: This piece discusses mental health issues. If you have experienced suicidal thoughts or have lost someone to suicide and want to seek help, you can contact the Crisis Text Line by texting "START" to 741-741 or call the Suicide Prevention Lifeline at 800-273-8255. [caption id="attachment_73822" align="alignleft" width="200"]Hampus Yngwe, MD, MScCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services Stockholm, Sweden Dr. Hampus Yngwe[/caption] MedicalResearch.com Interview with: Hampus Yngwe, MD, MSc Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, and Stockholm Health Care Services Stockholm, Sweden MedicalResearch.com: What is the background for this study? Response: Depression is a common and disabling condition and current treatments do not work for all patients. Psilocybin has shown promise as a rapid-acting treatment, but more controlled studies are needed to clarify its effects, durability and safety.

[caption id="attachment_73541" align="aligncenter" width="500"]can-two-people-get-sober-together.jpg pexels[/caption]

If you or someone you know is struggling or in crisis, help is available.

Call or text 988 or chat at 988lifeline.org. To learn how to get support for mental health, drug or alcohol conditions, visit FindSupport.gov. If you are ready to locate a treatment facility or provider, visit FindTreatment.gov or call 800-662-HELP (4357).

U.S. veterans or service members in crisis can call 988 then press "1" for the Veterans Crisis Line, text 838255, or chat online.

The Suicide & Crisis Lifeline has a Spanish language line at 1-888-628-9454 (toll-free).

It's the question every clinician has heard from a worried family member at intake: "They're both using. If we send them both to treatment, won't they just relapse together?" It's a fair question. It's also, according to a surprisingly robust body of research, the wrong one. The better question is whether the couple gets the right kind of treatment — because the data on couples in recovery is more nuanced, and more hopeful, than the conventional wisdom suggests.

[caption id="attachment_73528" align="alignleft" width="200"]Dr. Yuval Malka, PhDFaculty of Medicine Hebrew University and
Founder & CEO of Modular Therapeutics BV Dr. Yuval Malka, PhD[/caption] MedicalResearch.com Interview with Dr. Yuval Malka, PhD Faculty of Medicine Hebrew University and Founder & CEO of Modular Therapeutics BV and Dr. William Faller PhD University of Bristol discussing their new study on RNA dicing — a fundamental mechanism that generates multiple functional protein outputs from a single mRNA molecule — and its implications for cancer biology and therapeutics.

MedicalResearch.com: What is the background for this study?

Response: This study is a follow-up to previous work published in recent years (Malka et al., Nature Communications 2017; Malka et al., Molecular Cell 2022), in which we discovered that the mRNA of thousands of genes can be further processed into smaller fragments that translate into shorter proteins. On one hand, this finding helps bridge the gap between our understanding of the transcriptome - traditionally limited to ~20,000 genes and the proteome, which contains hundreds of thousands to potentially millions of distinct protein and peptide isoforms. On the other hand, those earlier studies did not provide sufficient biological insight into this extensive and robust process. The current study represents the third part of this trilogy, introducing a new concept in RNA biology termed "RNA dicing." We show that RNA dicing in eukaryotic systems enables the production of multiple functional protein outputs from a single mRNA molecule. How does this work? Most proteins consist of several domains, each with a distinct function, for example, mediating protein–protein interactions, determining subcellular localization, or carrying catalytic activity. We demonstrate that RNA dicing selectively removes portions of the mRNA template, resulting in the translation of shorter proteins lacking specific domains. This leads to substantial changes in protein function, localization, and interaction partners. In simple terms, RNA dicing mediates modular gene expression.

MedicalResearch.com Interview with a VERTEX Spokesperson discussing suzetrigine (JOURNAVX®), a first-in-class non-opioid pain signal inhibitor, and new Phase 4 data presented at the 2026 Annual Regional Anesthesiology and Acute Pain Medicine meeting.

MedicalResearch.com: What is the background for this study?

Response: There is a critical need for effective, safe non-opioid analgesics to help manage pain and reduce reliance on opioids. Despite significant safety and tolerability concerns such as addiction, opioid use disorder (OUD) and gastrointestinal side effects, opioids remain a common approach for managing moderate-to-severe acute pain. Our recent phase 4, single-arm study assessing suzetrigine in patients who underwent arthroscopic orthopedic procedures or laparoscopic abdominal or gynecological procedures highlighted the transformative potential for suzetrigine to be used as part of an opioid-free multimodal therapy for patients with moderate-to-severe acute pain. JOURNAVX® (suzetrigine) is a first-in-class, prescription non-opioid pain signal inhibitor for the treatment of moderate-to-severe acute pain, including postoperative pain, in adults. It works by selectively inhibiting the NaV1.8 sodium channel on peripheral nociceptors and, therefore, is not believed to have the addiction potential and tolerability issues associated with centrally acting opioids.

[caption id="attachment_73342" align="aligncenter" width="500"]knee-compression-osteoarthritis.jpg Photo by Terry Shultz P.T. on Unsplash[/caption] Symptomatic knee osteoarthritis affects roughly 13.8 percent of adults over 40, making it one of the most common causes of chronic joint pain worldwide. As clinicians increasingly prioritize conservative management over early pharmacological intervention, non-pharmacological strategies have gained renewed attention. Among these, compression bracing has emerged as a subject of growing research interest, with recent meta-analyses suggesting measurable benefits for pain, stiffness, and physical function. A body of evidence now supports the idea that compression knee support shown to improve joint proprioception through stimulation of cutaneous mechanoreceptors surrounding the joint capsule. This mechanism, first described in biomechanical research published in the Journal of Sports Science & Medicine (PubMed 15388537), offers a physiological rationale for what many patients report anecdotally: that wearing a compression sleeve makes the knee feel more stable during movement. For clinicians weighing treatment options, the question is no longer whether bracing has a role in osteoarthritis care, but which type of brace matches a given patient's needs.

Shoulder Specialist in Frisco.png Shoulder pain or limited mobility can affect every aspect of your life — from playing sports to performing simple daily activities. When it comes to shoulder care in Frisco, Dr. Paul Ghattas is aCh orthopaedic specialist known for combining advanced medical expertise with compassionate, patient-focused treatment. Recognised for his skill in shoulder arthroscopy and minimally invasive procedures, Dr. Ghattas helps patients regain strength, restore mobility, and live pain-free. Patients seeking the a shoulder surgeon in Frisco choose Dr. Ghattas for his precise care, innovative techniques, and consistent outcomes. Whether you are dealing with arthritis, sports injuries, or complex shoulder conditions, he provides solutions tailored to your individual needs.

[caption id="attachment_72900" align="alignleft" width="200"]MedicalResearch.com Interview with:Jakob Norgren | PhD, Postdoctoral Researcher Department of Neurobiology, Care Sciences and Society (NVS) | Karolinska Institutet Division of Clinical Geriatrics | Center for Alzheimer Research Huddinge, Sweden Jakob Norgren, Ph.D.[/caption] MedicalResearch.com Interview with: Jakob Norgren | PhD, Postdoctoral Researcher Department of Neurobiology, Care Sciences and Society (NVS) | Karolinska Institutet Division of Clinical Geriatrics | Center for Alzheimer Research Huddinge, Sweden     MedicalResearch.com: What is the background for this study? Response: This study tested the hypothesis that people with APOE 3/4 and 4/4 would have a reduced risk of cognitive decline and dementia with higher meat intake, based on the fact that APOE4 is the evolutionarily oldest variant of the APOE gene and may have arisen during a period when our evolutionary ancestors ate a more animal-based diet.

[caption id="attachment_72893" align="alignleft" width="200"]MedicalResearch.com Interview with:Francis J. Gesel Geisinger Commonwealth School of Medicine Scranton, Pennsylvania Francis J. Gesel[/caption] MedicalResearch.com Interview with: Francis J. Gesel Geisinger Commonwealth School of Medicine Scranton, Pennsylvania MedicalResearch.com: What is the background for this study? Response: Conflicts of interest (COIs) in psychiatric research represent a longstanding ethical challenge, given the close relationship between the pharmaceutical industry and psychiatry. Journals require authors to disclose these relationships, while the U.S. Open Payments database, created under the Sunshine Act, provides a record of payments from manufacturers to physicians. However, whether physician-authors in psychiatry’s most influential journals consistently disclose these relationships had not been systematically assessed. We focused on the American Journal of Psychiatry (AJP) and JAMA Psychiatry (JAMA-PSY), two of the highest-impact journals in the field, to evaluate the prevalence and magnitude of undisclosed financial COIs.